Palvella Therapeutics Inc (PVLA)
27.43 -0.18 (-0.65%) 16:05 ET [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Thu, Mar 20th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,543 | -33,277 | -45,738 | -37,230 | -25,469 |
| Depreciation Amortization | 1,904 | 2,770 | 2,459 | 2,311 | 632 |
| Income taxes - deferred | N/A | N/A | N/A | 164 | N/A |
| Accounts receivable | 5,307 | -2,624 | -1,813 | 5,343 | -4,055 |
| Accounts payable and accrued liabilities | -789 | -4,208 | 7,049 | -4,354 | 1,257 |
| Other Working Capital | -48,141 | -33,370 | 30,525 | -16,377 | -32,121 |
| Other Operating Activity | 12,443 | 10,777 | -142 | 4,247 | 7,289 |
| Operating Cash Flow | $-53,819 | $-59,932 | $-7,660 | $-45,896 | $-52,467 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -171 | -1,041 | -949 | -2,726 | -2,462 |
| Purchase Of Investment | -22,835 | -48,395 | N/A | -41,499 | -59,317 |
| Sale Of Investment | 35,008 | 28,200 | N/A | 83,437 | 71,617 |
| Investing Cash Flow | $12,002 | $-21,236 | $-949 | $39,212 | $9,838 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,795 | 7,214 | 59,127 | 10,115 | 32,166 |
| Financing Cash Flow | $19,795 | $7,214 | $59,127 | $10,115 | $32,166 |
| Exchange Rate Effect | 783 | -5,175 | -3,190 | 4,745 | -2,144 |
| Beginning Cash Position | 38,635 | 117,764 | 70,436 | 62,260 | 74,867 |
| End Cash Position | 17,396 | 38,635 | 117,764 | 70,436 | 62,260 |
| Net Cash Flow | $-21,239 | $-79,129 | $47,328 | $8,176 | $-12,607 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,819 | -59,932 | -7,660 | -45,896 | -52,467 |
| Capital Expenditure | -171 | -1,041 | -949 | -2,726 | -2,462 |
| Free Cash Flow | -53,990 | -60,973 | -8,609 | -48,622 | -54,929 |